99% Savings - Buy Just @1 Rs X
Loxacon 25 Mg Capsule is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Schizophrenia.
The optimal dosage of Loxacon 25 Mg Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Loxacon 25 Mg Capsule can also lead to other problems, which have been listed below. Usually, these side effects of Loxacon 25 Mg Capsule go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Loxacon 25 Mg Capsule has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Loxacon 25 Mg Capsule related warnings talks about Loxacon 25 Mg Capsule's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Heart Disease must refrain from the use of Loxacon 25 Mg Capsule since this can cause severe adverse effects. Other conditions have been mentioned below in the Loxacon 25 Mg Capsule contraindications section.
Drug interactions for Loxacon 25 Mg Capsule have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Loxacon 25 Mg Capsule is not safe while driving, and is is not addictive in nature.
Loxacon 25 Mg Capsule is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Loxacon 25 Mg Capsule safe for pregnant women?
Loxacon can have harmful effects in pregnant women. If you experience any discomfort after using Loxacon, then discontinue the use and take your doctor's advice.
Is the use of Loxacon 25 Mg Capsule safe during breastfeeding?
Loxacon should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Loxacon 25 Mg Capsule on the Kidneys?
Loxacon rarely affects the kidneys.
What is the effect of Loxacon 25 Mg Capsule on the Liver?
Loxacon may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Loxacon 25 Mg Capsule on the Heart?
Loxacon may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Loxacon 25 Mg Capsule unless your doctor advises you to do so -
Is this Loxacon 25 Mg Capsule habit forming or addictive?
Loxacon 25 Mg Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Loxacon 25 Mg Capsule, you should not drive or work on any heavy machine, as Loxacon 25 Mg Capsule can make you drowsy.
Is it safe?
Loxacon 25 Mg Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Loxacon 25 Mg Capsule works for mental disorders.
Interaction between Food and Loxacon 25 Mg Capsule
Some foods when eaten with Loxacon 25 Mg Capsule can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Loxacon 25 Mg Capsule
Consuming Loxacon 25 Mg Capsule with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Loxitane® (Loxapine Succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,441